DK149589D0 - Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme - Google Patents

Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme

Info

Publication number
DK149589D0
DK149589D0 DK149589A DK149589A DK149589D0 DK 149589 D0 DK149589 D0 DK 149589D0 DK 149589 A DK149589 A DK 149589A DK 149589 A DK149589 A DK 149589A DK 149589 D0 DK149589 D0 DK 149589D0
Authority
DK
Denmark
Prior art keywords
hiv
muterated
producing same
dna
dna sequence
Prior art date
Application number
DK149589A
Other languages
English (en)
Other versions
DK149589A (da
Inventor
Joseph Mccrary Mccune
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of DK149589D0 publication Critical patent/DK149589D0/da
Publication of DK149589A publication Critical patent/DK149589A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK149589A 1988-03-28 1989-03-28 Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme DK149589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17400588A 1988-03-28 1988-03-28

Publications (2)

Publication Number Publication Date
DK149589D0 true DK149589D0 (da) 1989-03-28
DK149589A DK149589A (da) 1989-09-29

Family

ID=22634418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK149589A DK149589A (da) 1988-03-28 1989-03-28 Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme

Country Status (5)

Country Link
EP (1) EP0335635A1 (da)
JP (1) JPH029372A (da)
AU (1) AU3170089A (da)
DK (1) DK149589A (da)
IL (1) IL89567A0 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
GB8923123D0 (en) 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
AU647108B2 (en) * 1990-04-03 1994-03-17 Genentech Inc. Methods and compositions for vaccination against HIV
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
EP0537247A4 (en) * 1990-06-19 1993-09-08 Immuvax Nonpathogenic variant virus
WO1992006113A2 (en) * 1990-09-28 1992-04-16 Smithkline Beecham Biologicals (S.A.) DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT
GB9106048D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccines
ES2115622T5 (es) * 1990-10-17 2003-03-16 Us Health Clones moleculares de hiv-1 y usos de los mismos.
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
ES2196005T3 (es) * 1992-03-27 2003-12-16 Int Flower Dev Pty Ltd Secuencias geneticas que codifican enzimas de la ruta flavonoide con actividad flavonoide -3`-hidroxilasa y sus usos.
US6174666B1 (en) 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
US6140059A (en) * 1993-01-16 2000-10-31 Schawaller; Manfred Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognition sites.
WO1994028929A1 (en) 1993-06-07 1994-12-22 Genentech, Inc. Hiv envelope polypeptides
US5795737A (en) * 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US6114148C1 (en) * 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
US20020106798A1 (en) * 2000-03-02 2002-08-08 Robinson Harriet L. DNA expression vectors and methods of use
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
EP2302059A1 (en) 2000-08-14 2011-03-30 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization
CN100446812C (zh) 2001-03-08 2008-12-31 美国国有健康与人类服务部 表达修饰的hiv包膜、gag和pol基因的mva
ES2339762T3 (es) * 2002-01-14 2010-05-25 Novartis Vaccines And Diagnostics, Inc. Vacuna contra el vih y procedimiento de uso.
CN112225798B (zh) 2011-05-17 2023-07-18 洛克菲勒大学 人类免疫缺陷病毒中和抗体及其使用方法
WO2014039561A1 (en) * 2012-09-04 2014-03-13 Mbio Diagnostics, Inc. System and method for improving biomarker assay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2606029B2 (fr) * 1986-04-08 1989-02-03 Transgene Sa Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
JPS63258575A (ja) * 1986-12-15 1988-10-26 レプリゲン　コーポレーション 昆虫細胞中でつくられる組換えｈｉｖエンベロープタンパク

Also Published As

Publication number Publication date
DK149589A (da) 1989-09-29
IL89567A0 (en) 1989-09-10
EP0335635A1 (en) 1989-10-04
JPH029372A (ja) 1990-01-12
AU3170089A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
DK210283D0 (da) Fremgangsmade til fremstilling af plasma, plasmapraeparat og vaccine mod hepatitis
DK166087A (da) Htlv-iii-virusprotein, dna-sekvens, der koder herfor, fremgangsmaade til fremstilling heraf, fremgangsmaade til detektion af aids-virus samt antistoffer mod aids-virus
NO871025D0 (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
FI871362A7 (fi) Virusrokote.
DK57391D0 (da) Hiv proteiner og peptider til anvendelse ved diagnosticering, profylakse og behandling af aids
NL930133I2 (nl) Vaccin tegen hepatitis B virus, werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin.
EP0276279A4 (en) COMPOSITION AND METHOD FOR IMMUNIZATION AGAINST VIRAL AIDS AND ARC AGENTS.
DK61792A (da) Fremgangsmaade til fremstilling af 2-chlor-4,6-diamino-5-cyano-pyrimidin
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
DK54184D0 (da) Dna-sekvenser,rekombinations-dna-molekyler samt fremgangsmaader til fremstilling af human(interleukin)to-lignende polipeptider
DK438288D0 (da) Hybrid picornavirus samt fremgangsmaade til fremstilling deraf og vaccine paa basis af en saadan virus
DK157089A (da) Ziegler-natta-katalysator, fremgangsmaade til fremstilling heraf og anvendelse af samme
FI833205A7 (fi) Menetelmä hepatitis B-virusrokotteen valmistamiseksi.
DK401787A (da) Spraenghoved og metode til fremstilling af samme
DK44788D0 (da) Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion
DK282384D0 (da) Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet
FI892683A7 (fi) Menetelmä ei-hyperglykosyloitujen hepatiitti-B-virusproteiinien tuottamiseksi
DK592284D0 (da) Toxoid, vaccinepraeparat indeholdende det og fremgangsmaade til fremstilling af det
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
FI872310A7 (fi) Menetelmä indiumin, germaniumin ja/tai galliumin talteenottamiseksi.
DK417787D0 (da) Fremgangsmaade til fremstilling af 7-oxo-4-thia-1-azabicyclo-(3,2,0)hept-2-en-derivater
DK448687A (da) Dna, der koder for et virusantigen
DK224187D0 (da) Cycliske peptider, deres fremstilling og anvendelse
NO894821D0 (no) Homopolysakkarid, opploesning derav, og deres fremstillingog anvendelse.
DK510387A (da) Fremgangsmaade til fremstilling af 3-dimethylamino-7-methyl-1,2,4-benzotriazin-1-oxid og azapropazon

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment